EyePoint Pharmaceuticals, Inc. (EYPT) PT Lowered to $4 at B.Riley/FBR
Tweet
Share
E-mailGet Alerts EYPT Hot Sheet
Price: $4.79 +4.59%
Rating Summary:
10 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
10 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
B.Riley/FBR analyst Andrew D\'Silva lowered the price target on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) to $4.00 (from $5.75) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Downgrades EyePoint Inc. (EYPT) to Hold
- MiniMed Group (MMED) PT Raised to $27 at StoneX on Conservative Revenue Guide
- Enovis Corp (ENOV) PT Lowered to $27 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
